Skin toxicity after chest wall/breast plus level III-IV lymph nodes treatment with helical tomotherapy. (26th November 2018)

• Record Type: Journal Article
• Authors: Lancellotta, Valentina; Chierchini, Sara; Perrucci, Elisabetta; Saldi, Simonetta; Falcinelli, Lorenzo; Iacco, Martina; Zucchetti, Claudio; Palumbo, Isabella; Bini, Vittorio; Aristei, Cynthia
• Is Part Of: Cancer investigation. Volume 36:Number 9/10(2018)
• Page Start: 504
• Page End: 511
• Publication Date: 2018-11-26
• Subjects: breast cancer -- radiotherapy -- skin toxicity -- helical tomotherapy; Cancer -- Periodicals; Oncology -- Periodicals; Medical Oncology -- Periodicals; Neoplasms -- Periodicals; 616.994
• DOI: 10.1080/07357907.2018.1545854
• Languages: English
• ISSNs: 0735-7907

Abstract

Abstract: Introduction: To evaluate the incidence of toxicity in breast cancer with helical tomotherapy (HT). Materials and Methods: 51 patients with breast cancer were assigned to postoperative radiotherapy by means of HT to the chest wall/breast plus draining nodes. During HT treatment, toxicity was monitored and were assessed using the Common Terminology Criteria for Adverse Events 4.0 scale. Results: Acute skin G3 toxicity observed in 1.9% cases. No acute or late G4 toxicity was observed. At a median follow-up of 21 months 2 patients have late G1 toxicity. Conclusions: HT was associated with a low incidence of low-grade skin toxicity.